Valuation: Novartis AG

Market Cap 301B 261B 243B 224B 421B 28,703B 429B 2,871B 1,124B 14,256B 1,129B 1,104B 47,940B P/E 2026 *
22.5x
P/E 2027 * 19.2x
Enterprise Value 334B 290B 269B 248B 468B 31,865B 476B 3,187B 1,248B 15,826B 1,253B 1,226B 53,220B EV / Sales 2026 *
5.8x
EV / Sales 2027 * 5.37x
Free-Float
91.66%
Yield 2026 *
2.76%
Yield 2027 * 2.88%
1 day-2.24%
1 week-0.69%
Current month+0.16%
1 month+0.16%
3 months+9.39%
6 months+10.61%
Current year+15.68%
1 week 126.14
Extreme 126.14
131.5
1 month 121.06
Extreme 121.06
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 91.56
Extreme 91.56
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
2/17/26 A Sell 30,743 0.0015%
2/10/26 A Sell 7,500 0.0004%
2/9/26 A Sell 30,160 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
-2.28%-0.69%+33.42%+39.21% 301B
-4.17%-2.01%+52.89%+155.66% 1,079B
-3.72%-1.27%+53.04%+52.79% 640B
-1.92%+0.54%+36.44%+72.68% 465B
-2.29%+1.12%+36.13%+30.60% 353B
-3.15%+0.25%+10.63%+13.71% 271B
-2.12%+3.31%+1.82%-39.41% 228B
-0.77%+3.58%+27.68%+64.33% 209B
-2.18%-0.77%+13.15%+70.55% 165B
-1.37%-0.96%+4.03%-31.31% 143B
Average -2.41%+4.47%+26.92%+42.88% 385.3B
Weighted average by Cap. -2.94%+4.73%+37.00%+70.98%

Financials

2026 *2027 *
Net sales 57.58B 50.02B 46.45B 42.84B 80.69B 5,497B 82.15B 550B 215B 2,730B 216B 212B 9,182B 61.12B 53.09B 49.3B 45.47B 85.65B 5,835B 87.2B 584B 229B 2,898B 230B 225B 9,746B
Net income 13.78B 11.97B 11.12B 10.25B 19.31B 1,316B 19.66B 132B 51.52B 653B 51.75B 50.62B 2,197B 15.36B 13.34B 12.39B 11.42B 21.52B 1,466B 21.91B 147B 57.42B 728B 57.67B 56.41B 2,449B
Net Debt 33.11B 28.76B 26.71B 24.63B 46.4B 3,161B 47.24B 316B 124B 1,570B 124B 122B 5,280B 27.82B 24.16B 22.44B 20.69B 38.98B 2,656B 39.68B 266B 104B 1,319B 104B 102B 4,436B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
30/07/26 CHF 126.78 -2.28% 2,232,247
29/07/26 CHF 129.74 -0.51% 2,331,609
28/07/26 CHF 130.40 +1.46% 2,558,238
27/07/26 CHF 128.52 +1.28% 2,435,055
24/07/26 CHF 126.90 -0.60% 1,859,367
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
158.18USD
Average target price
153.99USD
Spread / Average Target
-2.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock